Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non‐Hispanic subjects with cystic fibrosis in the United States

Background Hispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non‐Hispanic white subjects. The ethnic disparity in mortality varies by region. Factors influencing pulmonary function vary by both ethnicity and region. Objective To determine if the ethnic differenc...

Full description

Saved in:
Bibliographic Details
Published inPediatric pulmonology Vol. 54; no. 9; pp. 1382 - 1390
Main Authors McGarry, Meghan E., Neuhaus, John M., Nielson, Dennis W., Ly, Ngoc P.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Hispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non‐Hispanic white subjects. The ethnic disparity in mortality varies by region. Factors influencing pulmonary function vary by both ethnicity and region. Objective To determine if the ethnic difference in pulmonary function varies by region. Methods This retrospective cohort study compared differences in longitudinal pulmonary function (percent‐predicted forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], forced expiratory flow at 25% to 75% [FEF25‐75], FEV1/FVC, and FEV1 decline) between Hispanic and non‐Hispanic white subjects with CF by Census region of the United States (West, South, Midwest, and Northeast). Subjects were of ages 6 to 25 years and in the CF Foundation Patient Registry from 2008 to 2013. We used linear mixed effects models with subject‐specific slopes and intercepts, adjusting for 14 demographic and clinical variables. Results Of 14 932 subjects, 1433 (9.6%) were Hispanic and 13 499 (90.4%) were non‐Hispanic white. Hispanic subjects’ FEV1 was 9.0% (8.3%‐9.8%) lower than non‐Hispanic white subjects in the West, while Hispanic subjects’ FEV1 was only 4.0% (3.0%‐5.0%) lower in the Midwest, 4.4% (3.1%‐5.7%) lower in the Northeast, and 4.4% (3.2%‐5.5%) lower in the South. Similarly, FVC and FEF25‐75 were lower among Hispanic subjects compared to non‐Hispanic white subjects in all US regions, with the biggest differences in the West. Only in the West was FEV1/FVC significantly lower in Hispanic subjects (−0.019; −0.022 to −0.015). FEV1 decline was not significantly different between ethnicities in any region. Conclusions In CF, Hispanic subjects have lower pulmonary function than non‐Hispanic white subjects in all geographic regions with the largest difference in occurring in the West.
AbstractList BackgroundHispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non‐Hispanic white subjects. The ethnic disparity in mortality varies by region. Factors influencing pulmonary function vary by both ethnicity and region.ObjectiveTo determine if the ethnic difference in pulmonary function varies by region.MethodsThis retrospective cohort study compared differences in longitudinal pulmonary function (percent‐predicted forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], forced expiratory flow at 25% to 75% [FEF25‐75], FEV1/FVC, and FEV1 decline) between Hispanic and non‐Hispanic white subjects with CF by Census region of the United States (West, South, Midwest, and Northeast). Subjects were of ages 6 to 25 years and in the CF Foundation Patient Registry from 2008 to 2013. We used linear mixed effects models with subject‐specific slopes and intercepts, adjusting for 14 demographic and clinical variables.ResultsOf 14 932 subjects, 1433 (9.6%) were Hispanic and 13 499 (90.4%) were non‐Hispanic white. Hispanic subjects’ FEV1 was 9.0% (8.3%‐9.8%) lower than non‐Hispanic white subjects in the West, while Hispanic subjects’ FEV1 was only 4.0% (3.0%‐5.0%) lower in the Midwest, 4.4% (3.1%‐5.7%) lower in the Northeast, and 4.4% (3.2%‐5.5%) lower in the South. Similarly, FVC and FEF25‐75 were lower among Hispanic subjects compared to non‐Hispanic white subjects in all US regions, with the biggest differences in the West. Only in the West was FEV1/FVC significantly lower in Hispanic subjects (−0.019; −0.022 to −0.015). FEV1 decline was not significantly different between ethnicities in any region.ConclusionsIn CF, Hispanic subjects have lower pulmonary function than non‐Hispanic white subjects in all geographic regions with the largest difference in occurring in the West.
Hispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non-Hispanic white subjects. The ethnic disparity in mortality varies by region. Factors influencing pulmonary function vary by both ethnicity and region.BACKGROUNDHispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non-Hispanic white subjects. The ethnic disparity in mortality varies by region. Factors influencing pulmonary function vary by both ethnicity and region.To determine if the ethnic difference in pulmonary function varies by region.OBJECTIVETo determine if the ethnic difference in pulmonary function varies by region.This retrospective cohort study compared differences in longitudinal pulmonary function (percent-predicted forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1 ], forced expiratory flow at 25% to 75% [FEF25-75 ], FEV1 /FVC, and FEV1 decline) between Hispanic and non-Hispanic white subjects with CF by Census region of the United States (West, South, Midwest, and Northeast). Subjects were of ages 6 to 25 years and in the CF Foundation Patient Registry from 2008 to 2013. We used linear mixed effects models with subject-specific slopes and intercepts, adjusting for 14 demographic and clinical variables.METHODSThis retrospective cohort study compared differences in longitudinal pulmonary function (percent-predicted forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1 ], forced expiratory flow at 25% to 75% [FEF25-75 ], FEV1 /FVC, and FEV1 decline) between Hispanic and non-Hispanic white subjects with CF by Census region of the United States (West, South, Midwest, and Northeast). Subjects were of ages 6 to 25 years and in the CF Foundation Patient Registry from 2008 to 2013. We used linear mixed effects models with subject-specific slopes and intercepts, adjusting for 14 demographic and clinical variables.Of 14 932 subjects, 1433 (9.6%) were Hispanic and 13 499 (90.4%) were non-Hispanic white. Hispanic subjects' FEV1 was 9.0% (8.3%-9.8%) lower than non-Hispanic white subjects in the West, while Hispanic subjects' FEV1 was only 4.0% (3.0%-5.0%) lower in the Midwest, 4.4% (3.1%-5.7%) lower in the Northeast, and 4.4% (3.2%-5.5%) lower in the South. Similarly, FVC and FEF25-75 were lower among Hispanic subjects compared to non-Hispanic white subjects in all US regions, with the biggest differences in the West. Only in the West was FEV1 /FVC significantly lower in Hispanic subjects (-0.019; -0.022 to -0.015). FEV1 decline was not significantly different between ethnicities in any region.RESULTSOf 14 932 subjects, 1433 (9.6%) were Hispanic and 13 499 (90.4%) were non-Hispanic white. Hispanic subjects' FEV1 was 9.0% (8.3%-9.8%) lower than non-Hispanic white subjects in the West, while Hispanic subjects' FEV1 was only 4.0% (3.0%-5.0%) lower in the Midwest, 4.4% (3.1%-5.7%) lower in the Northeast, and 4.4% (3.2%-5.5%) lower in the South. Similarly, FVC and FEF25-75 were lower among Hispanic subjects compared to non-Hispanic white subjects in all US regions, with the biggest differences in the West. Only in the West was FEV1 /FVC significantly lower in Hispanic subjects (-0.019; -0.022 to -0.015). FEV1 decline was not significantly different between ethnicities in any region.In CF, Hispanic subjects have lower pulmonary function than non-Hispanic white subjects in all geographic regions with the largest difference in occurring in the West.CONCLUSIONSIn CF, Hispanic subjects have lower pulmonary function than non-Hispanic white subjects in all geographic regions with the largest difference in occurring in the West.
Background Hispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non‐Hispanic white subjects. The ethnic disparity in mortality varies by region. Factors influencing pulmonary function vary by both ethnicity and region. Objective To determine if the ethnic difference in pulmonary function varies by region. Methods This retrospective cohort study compared differences in longitudinal pulmonary function (percent‐predicted forced vital capacity [FVC], forced expiratory volume in 1 second [FEV1], forced expiratory flow at 25% to 75% [FEF25‐75], FEV1/FVC, and FEV1 decline) between Hispanic and non‐Hispanic white subjects with CF by Census region of the United States (West, South, Midwest, and Northeast). Subjects were of ages 6 to 25 years and in the CF Foundation Patient Registry from 2008 to 2013. We used linear mixed effects models with subject‐specific slopes and intercepts, adjusting for 14 demographic and clinical variables. Results Of 14 932 subjects, 1433 (9.6%) were Hispanic and 13 499 (90.4%) were non‐Hispanic white. Hispanic subjects’ FEV1 was 9.0% (8.3%‐9.8%) lower than non‐Hispanic white subjects in the West, while Hispanic subjects’ FEV1 was only 4.0% (3.0%‐5.0%) lower in the Midwest, 4.4% (3.1%‐5.7%) lower in the Northeast, and 4.4% (3.2%‐5.5%) lower in the South. Similarly, FVC and FEF25‐75 were lower among Hispanic subjects compared to non‐Hispanic white subjects in all US regions, with the biggest differences in the West. Only in the West was FEV1/FVC significantly lower in Hispanic subjects (−0.019; −0.022 to −0.015). FEV1 decline was not significantly different between ethnicities in any region. Conclusions In CF, Hispanic subjects have lower pulmonary function than non‐Hispanic white subjects in all geographic regions with the largest difference in occurring in the West.
Hispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non-Hispanic white subjects. The ethnic disparity in mortality varies by region. Factors influencing pulmonary function vary by both ethnicity and region. To determine if the ethnic difference in pulmonary function varies by region. This retrospective cohort study compared differences in longitudinal pulmonary function (percent-predicted forced vital capacity [FVC], forced expiratory volume in 1 second [FEV ], forced expiratory flow at 25% to 75% [FEF ], FEV /FVC, and FEV decline) between Hispanic and non-Hispanic white subjects with CF by Census region of the United States (West, South, Midwest, and Northeast). Subjects were of ages 6 to 25 years and in the CF Foundation Patient Registry from 2008 to 2013. We used linear mixed effects models with subject-specific slopes and intercepts, adjusting for 14 demographic and clinical variables. Of 14 932 subjects, 1433 (9.6%) were Hispanic and 13 499 (90.4%) were non-Hispanic white. Hispanic subjects' FEV was 9.0% (8.3%-9.8%) lower than non-Hispanic white subjects in the West, while Hispanic subjects' FEV was only 4.0% (3.0%-5.0%) lower in the Midwest, 4.4% (3.1%-5.7%) lower in the Northeast, and 4.4% (3.2%-5.5%) lower in the South. Similarly, FVC and FEF were lower among Hispanic subjects compared to non-Hispanic white subjects in all US regions, with the biggest differences in the West. Only in the West was FEV /FVC significantly lower in Hispanic subjects (-0.019; -0.022 to -0.015). FEV decline was not significantly different between ethnicities in any region. In CF, Hispanic subjects have lower pulmonary function than non-Hispanic white subjects in all geographic regions with the largest difference in occurring in the West.
Author Nielson, Dennis W.
Neuhaus, John M.
Ly, Ngoc P.
McGarry, Meghan E.
AuthorAffiliation 2 Department of Epidemiology and Biostatistics, University of California, San Francisco
1 Department of Pediatrics, University of California, San Francisco
AuthorAffiliation_xml – name: 1 Department of Pediatrics, University of California, San Francisco
– name: 2 Department of Epidemiology and Biostatistics, University of California, San Francisco
Author_xml – sequence: 1
  givenname: Meghan E.
  orcidid: 0000-0002-8562-7018
  surname: McGarry
  fullname: McGarry, Meghan E.
  email: Meghan.McGarry@ucsf.edu
  organization: University of California
– sequence: 2
  givenname: John M.
  surname: Neuhaus
  fullname: Neuhaus, John M.
  organization: University of California
– sequence: 3
  givenname: Dennis W.
  surname: Nielson
  fullname: Nielson, Dennis W.
  organization: University of California
– sequence: 4
  givenname: Ngoc P.
  surname: Ly
  fullname: Ly, Ngoc P.
  organization: University of California
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31144477$$D View this record in MEDLINE/PubMed
BookMark eNp9ksFu1DAQhi1URLeFCw-ALHFBlVKcOIljDkhVBRRpJSpgz5btjHe9ytohdlrtjUfoiQfkSXB2ywoqxMnWzPf_Hs_MCTpy3gFCz3NynhNSvO77sTsvSsrYIzTLCecZKXl9hGYNq6qsbmp6jE5CWBOScjx_go5pnpdlydgM_fgMS-ud7PCNHKyM6R6wdbjzbmnj2Noplfw3iRm22IxOT8wbfIG13_RJE7zD3uArG3rprMbStTgV-PP73SEURrUGHQO-tXGF9TbEFDRWDT7Y3WtxBXjhbIQWf4kyQniKHhvZBXh2f56ixft3Xy-vsvmnDx8vL-aZLsuGZTIHVUlKFGMNh1LWnACYFORUa6iNkromDWO8VAqk4ZRWxUQoagxpFaGn6O3etx_VBloNLg6yE_1gN-m7wksr_s44uxJLfyNqRgrCq2Tw6t5g8N9GCFFsbNDQddKBH4MoClqkRqcxJfTlA3TtxyH1d6JYxXlNeZOoF39WdCjl98gScLYHdGpfGMAckJyIaR_EtA9itw8JJg9gbeNuyuk3tvu3JN9Lbm0H2_-Yi-vrxXyv-QUjpc6K
CitedBy_id crossref_primary_10_1002_ppul_26445
crossref_primary_10_1016_j_jcf_2023_07_004
crossref_primary_10_1002_ppul_26209
crossref_primary_10_1002_jgc4_1271
crossref_primary_10_1016_j_ccm_2023_03_011
crossref_primary_10_1097_MCP_0000000000001005
crossref_primary_10_1016_j_jcf_2020_10_002
crossref_primary_10_1016_j_jnma_2021_08_038
crossref_primary_10_1002_ppul_25091
crossref_primary_10_1016_j_ccm_2022_06_002
crossref_primary_10_1214_22_AOAS1674
crossref_primary_10_1002_ppul_27155
crossref_primary_10_1002_ppul_24434
crossref_primary_10_1038_s41598_023_41868_x
crossref_primary_10_1016_j_prrv_2021_12_001
crossref_primary_10_1016_j_jcf_2024_09_009
crossref_primary_10_1177_23743735221112629
crossref_primary_10_1016_j_chest_2023_05_024
crossref_primary_10_1080_17476348_2022_2090928
crossref_primary_10_1183_23120541_00856_2020
crossref_primary_10_1016_j_jad_2022_12_110
crossref_primary_10_1002_ppul_25285
crossref_primary_10_1016_j_jcf_2021_09_006
crossref_primary_10_1016_j_jcf_2022_07_010
crossref_primary_10_1002_ppul_25882
crossref_primary_10_1016_j_rmed_2022_106953
Cites_doi 10.1164/rccm.201711-2357OC
10.1542/peds.2007-2906
10.1164/rccm.200306-779OC
10.1136/thx.2004.031153
10.1378/chest.116.3.639
10.1542/peds.111.4.e333
10.1016/j.jcf.2015.03.006
10.1289/ehp.6662
10.1513/AnnalsATS.201209-077OC
10.1002/ppul.23884
10.1164/rccm.201205-0913OC
10.1097/MCP.0b013e3283121cdc
10.1086/518313
10.1038/gim.2016.48
10.1136/thoraxjnl-2014-206622
10.1378/chest.14-2189
10.1513/AnnalsATS.201709-727OC
10.1371/journal.pone.0027784
10.1183/09031936.00080312
10.1513/AnnalsATS.201511-781OC
10.1164/ajrccm.163.6.9912100
10.1080/17476348.2016.1196140
10.1002/ppul.21037
10.1164/rccm.201205-0949OC
10.1016/j.pcl.2016.04.004
10.1016/j.healthplace.2014.12.016
10.1164/rccm.201405-0884OC
10.2747/0272-3638.20.8.727
10.1089/ped.2014.0396
10.1371/journal.pone.0094431
10.1016/j.jpeds.2015.01.052
10.1097/MCP.0b013e32834ba899
10.1542/peds.2006-1414
ContentType Journal Article
Copyright 2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2019 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
5PM
DOI 10.1002/ppul.24377
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1099-0496
EndPage 1390
ExternalDocumentID PMC6702095
31144477
10_1002_ppul_24377
PPUL24377
Genre article
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
United States--US
GeographicLocations_xml – name: United States
– name: United States--US
GrantInformation_xml – fundername: National Institutes of Health
  funderid: KL2 TR001870
– fundername: National Heart, Lung, and Blood Institute
  funderid: 1K23HL133437‐01A1; UG1HL139106; U10HL109146–01
– fundername: National Science Foundation
  funderid: IIP‐1622950
– fundername: Cystic Fibrosis Foundation Therapeutics
  funderid: CC029‐18; MCGARR16A0; LY18Y0
– fundername: National Institute of Diabetes and Digestive and Kidney Diseases
  funderid: P30 DK072517
– fundername: Vertex Pharmaceuticals
  funderid: VX‐7029098
– fundername: NHLBI NIH HHS
  grantid: UG1 HL139106
– fundername: NHLBI NIH HHS
  grantid: U10 HL109146
– fundername: NHLBI NIH HHS
  grantid: 1K23HL133437-01A1
– fundername: NIDDK NIH HHS
  grantid: P30 DK072517
– fundername: NIMHD NIH HHS
  grantid: L60 MD010865
– fundername: NCATS NIH HHS
  grantid: KL2 TR001870
– fundername: NHLBI NIH HHS
  grantid: K23 HL133437
– fundername: NHLBI NIH HHS
  grantid: U10HL109146-01
– fundername: NHLBI NIH HHS
  grantid: UG1HL139106
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
TEORI
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
5PM
ID FETCH-LOGICAL-c4487-a1eb5a30b7789e4a690eef1eb93cce6fbac6087794bbeaf933520eefb3ff0db03
IEDL.DBID DR2
ISSN 8755-6863
1099-0496
IngestDate Thu Aug 21 13:20:26 EDT 2025
Thu Jul 10 18:43:08 EDT 2025
Sun Jul 13 05:24:28 EDT 2025
Thu Apr 03 07:07:09 EDT 2025
Tue Jul 01 02:26:37 EDT 2025
Thu Apr 24 23:04:02 EDT 2025
Wed Jan 22 16:38:56 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords epidemiology
social dimensions of pulmonary medicine
cystic fibrosis
pulmonary function testing
Language English
License 2019 Wiley Periodicals, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4487-a1eb5a30b7789e4a690eef1eb93cce6fbac6087794bbeaf933520eefb3ff0db03
Notes The data presented in this study were previously presented at the North American Cystic Fibrosis Conference in November 2017 in Indianapolis, Indiana.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
Author contributions: MEM had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. MEM and JMN conducted the study analysis. MEM, JMN, DWN, and NPL contributed substantially to the study design, data interpretation, and the writing of the manuscript.
ORCID 0000-0002-8562-7018
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/6702095
PMID 31144477
PQID 2275996398
PQPubID 1036356
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6702095
proquest_miscellaneous_2232477002
proquest_journals_2275996398
pubmed_primary_31144477
crossref_primary_10_1002_ppul_24377
crossref_citationtrail_10_1002_ppul_24377
wiley_primary_10_1002_ppul_24377_PPUL24377
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2019
PublicationDateYYYYMMDD 2019-09-01
PublicationDate_xml – month: 09
  year: 2019
  text: September 2019
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Pediatric pulmonology
PublicationTitleAlternate Pediatr Pulmonol
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References e_1_2_9_1_14_1
e_1_2_9_1_37_1
e_1_2_9_1_36_1
e_1_2_9_1_12_1
e_1_2_9_1_35_1
e_1_2_9_1_13_1
e_1_2_9_1_34_1
e_1_2_9_1_10_1
e_1_2_9_1_33_1
e_1_2_9_1_11_1
e_1_2_9_1_32_1
e_1_2_9_1_31_1
e_1_2_9_1_30_1
e_1_2_9_1_2_1
e_1_2_9_1_3_1
e_1_2_9_1_4_1
e_1_2_9_1_5_1
e_1_2_9_1_6_1
Brooks T (e_1_2_9_1_15_1) 2017
Kuczmarski RJ (e_1_2_9_1_22_1) 2000; 314
e_1_2_9_1_29_1
e_1_2_9_1_27_1
e_1_2_9_1_28_1
e_1_2_9_1_25_1
e_1_2_9_1_26_1
e_1_2_9_1_23_1
e_1_2_9_1_24_1
e_1_2_9_1_21_1
e_1_2_9_1_20_1
e_1_2_9_1_41_1
e_1_2_9_1_40_1
e_1_2_9_1_7_1
e_1_2_9_1_8_1
e_1_2_9_1_9_1
López G (e_1_2_9_1_16_1) 2015
e_1_2_9_1_18_1
e_1_2_9_1_19_1
e_1_2_9_1_39_1
e_1_2_9_1_17_1
e_1_2_9_1_38_1
References_xml – ident: e_1_2_9_1_3_1
  doi: 10.1164/rccm.201711-2357OC
– ident: e_1_2_9_1_29_1
  doi: 10.1542/peds.2007-2906
– ident: e_1_2_9_1_36_1
  doi: 10.1164/rccm.200306-779OC
– ident: e_1_2_9_1_5_1
  doi: 10.1136/thx.2004.031153
– ident: e_1_2_9_1_12_1
  doi: 10.1378/chest.116.3.639
– ident: e_1_2_9_1_30_1
  doi: 10.1542/peds.111.4.e333
– ident: e_1_2_9_1_34_1
  doi: 10.1016/j.jcf.2015.03.006
– ident: e_1_2_9_1_37_1
  doi: 10.1289/ehp.6662
– ident: e_1_2_9_1_26_1
  doi: 10.1513/AnnalsATS.201209-077OC
– ident: e_1_2_9_1_4_1
  doi: 10.1002/ppul.23884
– ident: e_1_2_9_1_11_1
  doi: 10.1164/rccm.201205-0913OC
– ident: e_1_2_9_1_27_1
  doi: 10.1097/MCP.0b013e3283121cdc
– ident: e_1_2_9_1_17_1
  doi: 10.1086/518313
– ident: e_1_2_9_1_33_1
  doi: 10.1038/gim.2016.48
– ident: e_1_2_9_1_38_1
  doi: 10.1136/thoraxjnl-2014-206622
– ident: e_1_2_9_1_2_1
  doi: 10.1378/chest.14-2189
– ident: e_1_2_9_1_25_1
  doi: 10.1513/AnnalsATS.201709-727OC
– ident: e_1_2_9_1_9_1
  doi: 10.1371/journal.pone.0027784
– ident: e_1_2_9_1_20_1
  doi: 10.1183/09031936.00080312
– ident: e_1_2_9_1_40_1
– ident: e_1_2_9_1_18_1
– ident: e_1_2_9_1_41_1
  doi: 10.1513/AnnalsATS.201511-781OC
– ident: e_1_2_9_1_8_1
  doi: 10.1164/ajrccm.163.6.9912100
– ident: e_1_2_9_1_6_1
  doi: 10.1080/17476348.2016.1196140
– ident: e_1_2_9_1_24_1
  doi: 10.1002/ppul.21037
– ident: e_1_2_9_1_28_1
  doi: 10.1164/rccm.201205-0949OC
– ident: e_1_2_9_1_21_1
– volume: 314
  start-page: 1
  year: 2000
  ident: e_1_2_9_1_22_1
  article-title: CDC growth charts: United States
  publication-title: Adv Data
– ident: e_1_2_9_1_14_1
  doi: 10.1016/j.pcl.2016.04.004
– ident: e_1_2_9_1_39_1
  doi: 10.1016/j.healthplace.2014.12.016
– ident: e_1_2_9_1_10_1
  doi: 10.1164/rccm.201405-0884OC
– volume-title: The Impact of Slowing Immigration: Foreign‐Born Share Falls Among 14 Largest U.S. Hispanic Groups
  year: 2015
  ident: e_1_2_9_1_16_1
– ident: e_1_2_9_1_23_1
  doi: 10.2747/0272-3638.20.8.727
– ident: e_1_2_9_1_19_1
– ident: e_1_2_9_1_31_1
  doi: 10.1089/ped.2014.0396
– ident: e_1_2_9_1_13_1
  doi: 10.1371/journal.pone.0094431
– ident: e_1_2_9_1_35_1
  doi: 10.1016/j.jpeds.2015.01.052
– ident: e_1_2_9_1_7_1
  doi: 10.1097/MCP.0b013e32834ba899
– volume-title: Medicaid and CHIP Eligibility, Enrollment, Renewal, and Cost Sharing Policies as of January 2017: Findings from a 50‐state survey
  year: 2017
  ident: e_1_2_9_1_15_1
– ident: e_1_2_9_1_32_1
  doi: 10.1542/peds.2006-1414
SSID ssj0009991
Score 2.3875906
Snippet Background Hispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non‐Hispanic white subjects. The ethnic disparity in...
Hispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non-Hispanic white subjects. The ethnic disparity in mortality varies...
BackgroundHispanic subjects with cystic fibrosis (CF) have increased morbidity and mortality than non‐Hispanic white subjects. The ethnic disparity in...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1382
SubjectTerms Adolescent
Adult
Child
Cultural differences
Cystic fibrosis
Cystic Fibrosis - ethnology
Cystic Fibrosis - physiopathology
epidemiology
European Continental Ancestry Group
Female
Forced Expiratory Volume
Hispanic Americans
Hispanic people
Humans
Linear Models
Lung - physiopathology
Male
pulmonary function testing
Respiratory Function Tests
Retrospective Studies
social dimensions of pulmonary medicine
United States
Vital Capacity
Young Adult
Title Regional variations in longitudinal pulmonary function: A comparison of Hispanic and non‐Hispanic subjects with cystic fibrosis in the United States
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fppul.24377
https://www.ncbi.nlm.nih.gov/pubmed/31144477
https://www.proquest.com/docview/2275996398
https://www.proquest.com/docview/2232477002
https://pubmed.ncbi.nlm.nih.gov/PMC6702095
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fi9QwEB-OexBf9PxfPSWiLwrd222zTSO-HOKxiCfH4cK9SEnSRItLu1y3gj75EXzyA_pJnEm6XdcTQd9KOk3Sdib5zST5DcDjfKKyxEkRT0rN0UHRItaWT2Klcb41pVKZpNPIx2-y2Zy_Opue7cDz9VmYwA8xBNzIMvx4TQaudHuwIQ1dLrvFiOj06Cg5bdYiRHS64Y4i5BOCe9M4y7N04CZNDjaPbs9GFyDmxZ2SvyJYPwUdXYV3686HnScfR91Kj8yX33gd__ft9uBKj03ZYVCma7Bj6-tw6bhffb8B30_tex85ZJ_Qww6hPlbVbNFQ0qOupARbDGtEzcaGGU2ZJPOMHTIzpDtkjWOzCsexujJM1SWrm_rH129DUdtpCg21jCLEzHwmHmnm8F2atvKtIWJlASmzgJRvwvzo5dsXs7jP6xAbdAZFrCZWT1WKeiFyaTmqw9hah4UyNcZmTiuTEU-h5Fpb5SQdCyMJnTo3LvU4vQW72Dd7BxjCFXTJDNYrHc-d0UmJeCQVYwptpVxE8GT9fwvTk55T7o1FEeiak4I-dOE_dASPBtlloPr4o9T-Wk2K3tzbIkkE0dykMo_g4XAbDZVWX1Rtm45kELsKgbVFcDto1dBMil4p51S52NK3QYBIwLfv1NUHTwaeCQT8chrBU69Of-l5cXIyf-2v7v6L8D24jCCx31e3D7ur887eRyC20g-8wf0EGm82LA
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELagSNAL_z-BAkZwASnb3dgbx9wqRLXAblVVXam3yHZsiLpKVmSDBCcegRMPyJMwY6dZliIkuEXJxHaSmfib8fgbQp5lI5UmTop4VGgODooWsbZ8FCsN860plEol7kaeHaSTOX97Mj7pcnNwL0zgh-gDbmgZ_n-NBo4B6d01a-hy2S4GyKcnLpJLWNLbe1RHa_YoxD4hvDeO0yxlPTtpsru-d3M-Ogcyz-dK_oph_SS0fy1UWm08dyHmnpwO2pUemC-_MTv-9_NdJ1c7eEr3gj7dIBdsdZNcnnUL8LfI9yP73gcP6SdwskO0j5YVXdRY96gtsMYWhRZBuaFnirMmyryke9T0FQ9p7eikhF9ZVRqqqoJWdfXj67f-VNNqjA41FIPE1HxGKmnq4GHqpvS9AWilASzTAJZvk_n-6-NXk7gr7RAb8AdFrEZWjxUD1RCZtBw0Ymitg5OSGWNTp5VJkapQcq2tchJ3hqGEZs4NCz1kd8gWjM3eIxQQC3hlBtqVjmfO6KQASMLEEKNbjIuIPD_7wLnpeM-x_MYiD4zNSY4vOvcvOiJPe9llYPv4o9TOmZ7kncU3eZIIZLphMovIk_4y2CouwKjK1i3KAHwVAlqLyN2gVn03DBxTzrFxsaFwvQDygG9eqcoPng88FYD55TgiL7w-_WXk-eHhfOqP7v-L8GNyZXI8m-bTNwfvHpBtwIxdmt0O2Vp9bO1DwGUr_chb308-NzpH
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NIU28jPFzgQFG8AJSujRx4wTxMjGqAttUTVTaC4psx4aIKqlogwRP_Al74g_kL-EuTlPKEBK8VcnVdpLv4u8u9ncAj5O-jEObCr-fK44BihK-MrzvS4Xzrc6ljFPajXx8Eo8m_PXZ4GwDni_3wjh9iC7hRp7RvK_JwWe53V-Jhs5m9bRHcnriElzmcZAQpg9PV-JRRH1cdm_gx0kcdeKk4f7qv-vT0QWOeXGp5K8UtpmDhlfh3XL0bunJx169UD399Tdhx_-9vB3YbskpO3BougYbprwOW8ft5_cb8P3UvG9Sh-wzhtgu18eKkk0rqnpU51Rhi2GLCG3smNGcSTbP2AHTXb1DVlk2KvBFVhaayTJnZVX--HbeHZrXinJDc0YpYqa_kJA0s3gt1bxoekPKyhxVZo4q34TJ8OXbFyO_Lezga4wGhS_7Rg1khMAQSWo44iEwxuLBNNLaxFZJHZNQYcqVMtKmtC-MLFRkbZCrILoFmzg2swsM-QrGZBrbTS1PrFZhjoQkEgHltiIuPHiyfL6ZblXPqfjGNHN6zWFGNzprbrQHjzrbmdP6-KPV3hImWevv8ywMBencRGniwcPuNHoqfX6RpalqskHyKgS25sFth6qumwjDUs6pcbGGt86AVMDXz5TFh0YNPBbI-NOBB08bOP1l5Nl4PDlqft35F-MHsDU-HGZHr07e3IUrSBjbNXZ7sLn4VJt7SMoW6n7jez8BmVo4_w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Regional+variations+in+longitudinal+pulmonary+function%3A+A+comparison+of+Hispanic+and+non-Hispanic+subjects+with+cystic+fibrosis+in+the+United+States&rft.jtitle=Pediatric+pulmonology&rft.au=McGarry%2C+Meghan+E&rft.au=Neuhaus%2C+John+M&rft.au=Nielson%2C+Dennis+W&rft.au=Ly%2C+Ngoc+P&rft.date=2019-09-01&rft.issn=1099-0496&rft.eissn=1099-0496&rft.volume=54&rft.issue=9&rft.spage=1382&rft_id=info:doi/10.1002%2Fppul.24377&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8755-6863&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8755-6863&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8755-6863&client=summon